Reconsidering the Future of Precision Medicine

An article published in European Biopharmaceutical Review where we discuss the opportunity for metabolomics and breathomics in the future of precision medicine.

Euro Biopharma Review July 2021 Over the last 20 years, precision medicine has become a prominent theme in clinical and pharmaceutical research, aiming to target therapies more effectively to improve health and reduce pressure on healthcare services. So far, genetic tests have played a significant role in the advancement of precision medicine. Yet, in many cases, genomics provides limited insight into patient biology, while emerging tools could provide the detailed information that is needed to fully realise the potential of this approach.

Read the full article